FOR IMMEDIATE RELEASE: President of John Jay College of Criminal Justice Brings Wealth of Experience in Law Enforcement and Public Safety Programs, Technologies KINDERHOOK, N.Y. -- June 3, 2024 -- American Bio Medica Corporation (Nasdaq: ABMC) today announced that Dr. Gerald W. Lynch will join the ABMC board of directors effective July 1, 2002. Lynch is the president of John Jay College of Criminal Justice in New York, a position he has held since 1976. John Jay College of Criminal Justice is the nation's only liberal arts college devoted exclusively to the study of criminal justice, law enforcement, police science, public safety and public service. "We are extremely fortunate to have Dr. Lynch become an independent director for ABMC, because he has tremendous insights on both the present and the future of criminal justice and public safety in America and abroad. These are areas of vital interest and potential for ABMC," said ABMC Chairman and Chief Executive Officer Gerald Moore. "I am excited to be a member of the board of directors of this progressive and involved company, and I look forward to sharing my opinions on ways that ABMC and its products can tangibly benefit law enforcement and public safety professionals," said Lynch. An internationally known expert and advocate of criminal justice education, Lynch has lectured at the Ecole Nationale Superieure de Police in Lyon, France; the Police Staff College in Bramshill, England; St. Petersburg University, Russia; as well as at schools and conferences in Abu Dhabi, Australia, South Africa, Canada, Brazil, Spain, Hungary, Ireland, Mexico, Israel, Italy and Germany. He earned his doctorate in clinical psychology from New York University, and is a vice chairman of the New York City Police Foundation, and the chairman of The New York Fire Safety Foundation. Under Lynch's leadership, John Jay College has been recognized as the largest college for law enforcement studies in the world, attracting students from many nations. In its 2002 ratings U.S. News & World Report ranked John Jay College's Master of Public Administration Program first in the nation among programs with specializations in Criminal Justice Policy in the magazine's Graduate Rankings of Public Affairs Programs. About American Bio Medica Corporation American Bio Medica Corporation develops, manufactures and markets inexpensive, accurate, onsite drugs-of-abuse diagnostic kits and support services worldwide. The company and its worldwide distribution network target the workplace, government, corrections, clinical and educational markets. ABMC's Rapid Drug Screen®, Rapid One and Rapid Tec test for the presence or absence of drugs of abuse in urine, while its OralStat6 tests for the presence or absence of drugs of abuse in saliva. ABMC was recently listed among the top ten biotechnology companies on the Deloitte & Touche 2001 Technology Fast 500, a ranking of the fastest growing companies in North America. This release may contain forward-looking statements. These
forward-looking statements involve risks and uncertainties that could
cause actual results to differ, and such differences could be
material. Such risks and uncertainties include, but are not limited
to, the following: continued acceptance of the company's products,
increased levels of competition in our industry, the acceptance of new
products, inherent risks associated with product development and
intellectual property rights, the company's dependence on key
personnel, third party sales and suppliers. There can be no assurance
that the company will be successful in addressing such risks and
uncertainties. Investors are strongly encouraged to review the section
entitled "Risk Factors" in the company's annual report on Form 10-KSB
for the transition period ended Dec. 31, 2001, and quarterly reports
on Form 10-QSB on file with the Securities and Exchange Commission for
a discussion of risks and uncertainties that could affect operating
results and the market price of the company's common shares.
Contact: American Bio Medica Corporation, Kinderhook Gerald A. Moore, 800/227-1243 Fax: 518/758-8171 E-mail: gerald@americanbiomedica.com Web: www.americanbiomedica.com |